We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Tool That Identifies Patterns on CT Scans Offers New Promise for Treating Patients with Small Cell Lung Cancer

By MedImaging International staff writers
Posted on 26 Nov 2021
Print article
Illustration
Illustration

Researchers have used artificial intelligence (AI) to identify patterns on computed tomography (CT) scans that offer new promise for treating patients with small cell lung cancer.

The researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University (Cleveland, OH, USA) identified a set of radiomic patterns from CT scans taken before treatment that allow them to predict a patient’s response to chemotherapy. They also examined the association between AI-derived image features with longer-term outcomes.

Small cell lung cancer (SCLC) represents about 13% of all lung cancers, but grows faster and is more likely to spread than non-small cell lung cancer, according to the American Cancer Society. And while a lot of AI research has been performed on non-small cell lung cancer, little work has been done on SCLC. Small cell lung cancer patients can be challenging to treat. During their efforts to ascertain which SCLC patients would respond to treatment, the researchers found that computationally extracted textural patterns of the tumor itself - as well as the region surrounding it - were found to be different in SCLC patients who responded well to a certain chemotherapy, compared to those who did not.

Further, patterns were revealed by the AI that corresponded to patients who ended up living longer after treatment compared to those who did not. Finally, the AI revealed that there was notably more heterogeneity, or variability, in the scanned images of patients who did not respond to chemo and had poorer chances of survival. These findings from a retrospective study now sets the stage for prospective AI driven clinical trials for treatment management of SCLC patients. Their findings are significant because chemotherapy remains the backbone of systemic treatment, the researchers said. The study is part of broader research conducted at CCIPD to develop and apply novel AI and machine-learning approaches to diagnose and predict therapy responses for various diseases and indications of cancer, including breast, prostate, head and neck, brain, colorectal, gynecologic and skin cancer.

“Our efforts are aimed at reducing unnecessary chemotherapeutic treatments and thus reducing patient suffering,” said the study’s co-lead author Mohammadhadi Khorrami, a CCIPD researcher and PhD student in biomedical engineering at Case Western Reserve. “By knowing which patients will benefit from therapy, we can decrease ineffective treatments and increase more aggressive therapy in patients who have suboptimal or no response to the first-line therapy.”

Related Links:
Case Western Reserve University 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
X-Ray Detector
FDR-D-EVO III
New
Portable Radiology System
DRAGON ELITE & CLASSIC
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.